載入...
Product review on the Anti-PD-L1 antibody atezolizumab
Immunotherapy as a therapeutic strategy has seized the narrative throughout clinical oncology over the past few years. Once considered a niche treatment for rare cancers, immunotherapy has quickly emerged as the standard of care for many common cancer types. The remarkable rise is largely due to the...
Na minha lista:
| 發表在: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5806639/ https://ncbi.nlm.nih.gov/pubmed/29194007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1403694 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|